Gene · 5452
Papers3,227
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,227
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrated single cell multiomic profiling and functional validation reveal distinct cellular routes to human plasma cell differentiation. | bioRxiv | 2026 | 41756891 | PubTator, text mining | PubMed |
| Expression and significance analyses of microRNAs in colorectal cancer. | Mol Clin Oncol | 2026 | 41756135 | PubTator, text mining | PubMed |
| Translational Potential: Kidney Tubuloids in Precision Medicine and Regenerative Nephrology. | Pharmaceutics | 2026 | 41754890 | PubTator, text mining | PubMed |
| The Impact of Scleral Lenses on Intraocular Pressure. | J Clin Med | 2026 | 41753321 | PubTator, text mining | PubMed |
| Molecular Basis of Adenomatous Gastrointestinal Polyposis Syndromes: Role of Pathogenic and Benign Variants in Disease Onset. | Biomedicines | 2026 | 41751327 | PubTator, text mining | PubMed |
| DRG Explant Model for Understanding Mechanism of Oxaliplatin-Induced Peripheral Neuropathy and Identifying Potential Therapeutic Targets. | Antioxidants (Basel) | 2026 | 41750611 | PubTator, text mining | PubMed |
| Exploring Sulpiride as an Alternative to Testosterone Propionate for Inducing Benign Prostatic Hyperplasia in Rodent Models. | Toxics | 2026 | 41745854 | PubTator, text mining | PubMed |
| Case Report: A rare case of Epstein-Barr virus mucocutaneous ulcers occurring in the eyeball and literature review. | Front Med (Lausanne) | 2026 | 41743091 | PubTator, text mining | PubMed |
Computational approaches for the identification of potential HDAC2 inhibitors and histamine H3 receptor antagonists from Berberis vulgaris: a dual mechanistic approach for autism spectrum disorder treatment. | Open Life Sci | 2026 | 41737604 | PubTator, text mining | PubMed |
| Discover personalized drug opportunity and optimized tumor-infiltrating lymphocyte therapy for rare cancer: an organoid-based whole-journey clinical mapping study in a neuroendocrine cancer patient. | Cell Oncol (Dordr) | 2026 | 41733805 | PubTator, text mining | PubMed |
| Rare Sinonasal Case of IRF4-Rearranged Large B-Cell Lymphoma Mimicking Chronic Sinusitis. | J Investig Med High Impact Case Rep | 2026 | 41732840 | PubTator, text mining | PubMed |
| Integrated bioinformatics-based identification of proliferative diabetic retinopathy and idiopathic pulmonary fibrosis: Focus on fibrosis and immune infiltration. | PLoS One | 2026 | 41729975 | PubTator, text mining | PubMed |
| Sub-stoichiometric Degradation is Dispensable for Potent PROTACs: A Case Study for Irreversible Covalent BTK Degraders. | bioRxiv | 2026 | 41727153 | PubTator, text mining | PubMed |
| The quantitative impact of metabolism-inhibiting drugs on the occurrence of adverse drug reactions-A backward selection approach. | Br J Clin Pharmacol | 2026 | 41721490 | PubTator, text mining | PubMed |
| Unraveling Network Pharmacology-Based Therapeutics of Anthranilate Sulfonamides via Sirtuins/FOXO3a Cascade in Alzheimer's Disease. | J Neurochem | 2026 | 41714304 | PubTator, text mining | PubMed |
| A multifaceted analysis of OTUD5 integrated MAVS in innate immunity of Primary Biliary Cholangitis. | PLoS One | 2026 | 41650163 | PubTator, text mining | PubMed |
| Lamin A/C maintains genome topology and regulates transcriptional programs essential for virus-driven B cell activation. | bioRxiv | 2026 | 41648489 | PubTator, text mining | PubMed |
| The Effect of Ecopipam on the Pharmacokinetics of Concomitant Medications. | Clin Transl Sci | 2026 | 41635062 | PubTator, text mining | PubMed |
| Pseudo-Acute Kidney Injury With Tyrosine Kinase Inhibitors: Utility of the Creatinine-to-Cystatin C Ratio. | Kidney Int Rep | 2026 | 41568270 | PubTator, text mining | PubMed |
Understanding Pharmacokinetic-Drug Interactions With Drugs Approved by the US Food and Drug Administration in 2024 to Better Manage the Risk of Drug Interactions With Concomitant Medications: A Review of Clinical Data From New Drug Applications. | Curr Ther Res Clin Exp | 2026 | 41567854 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5452/papers?page=3